{"nctId":"NCT00706381","briefTitle":"Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)","startDateStruct":{"date":"2008-06-23"},"conditions":["Healthy Volunteers"],"count":31,"armGroups":[{"label":"1: Carb meal, fat meal, sincalide, placebo, urso","type":"EXPERIMENTAL","interventionNames":["Drug: Sincalide","Drug: Ursodiol","Procedure: Fat Meal","Procedure: Carb meal","Drug: Placebo"]},{"label":"2: Fat meal, carb meal, sincalide, placebo, urso","type":"EXPERIMENTAL","interventionNames":["Drug: Sincalide","Drug: Ursodiol","Procedure: Fat Meal","Procedure: Carb meal","Drug: Placebo"]},{"label":"3: Carb meal, fat meal, placebo, sincalide, urso","type":"EXPERIMENTAL","interventionNames":["Drug: Sincalide","Drug: Ursodiol","Procedure: Fat Meal","Procedure: Carb meal","Drug: Placebo"]},{"label":"4: Fat meal, carb meal, placebo, sincalide, urso","type":"EXPERIMENTAL","interventionNames":["Drug: Sincalide","Drug: Ursodiol","Procedure: Fat Meal","Procedure: Carb meal","Drug: Placebo"]}],"interventions":[{"name":"Sincalide","otherNames":[]},{"name":"Ursodiol","otherNames":[]},{"name":"Fat Meal","otherNames":[]},{"name":"Carb meal","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"* INCLUSION CRITERIA:\n\nAge greater than or equal to18 years, male or female\n\nWritten informed consent\n\nEXCLUSION CRITERIA:\n\nHypo- or hyperthyroidism (history or serum thyroid-stimulating hormone (TSH) greater than 5.0 or less than 0.4 miU/L)\n\nBlood pressure greater than 140/90 mmHg (26) or receiving antihypertensive therapy\n\nHistory of cardiovascular disease\n\nBMI less than or equal to 20 or greater than or equal to 27 Kg/m(2)\n\nDiabetes mellitus (fasting serum glucose greater than or equal to 126 mg/dL)\n\nHyperlipidemia (serum total cholesterol greater than or equal to 240 mg/dL, triglycerides greater than or equal to 220 mg/dL, and/or use of antilipemic therapy)\n\nLiver disease or ALT serum concentrations greater than 1.5 times the upper laboratory reference limit\n\nHyperbilirubinemia (serum total bilirubin greater than 1.5 mg/dL)\n\nRenal insufficiency or estimated creatinine clearance less than or equal to 50 mL/min (MDRD equation)\n\nAnemia (Hemoglobin concentration less than or equal to 11.1 g/dL females, and 12.7 g/dL males)\n\nHistory of cholecystectomy or cholelithiasis (by ultrasound at screening).\n\nHistory of malabsorption, or food allergies/intolerances that would preclude participant from consuming foods required for study\n\nClaustrophobia\n\nHistory of illicit drug or alcohol abuse within the last 5 years; current use of illicit drugs (by history) or alcohol (CAGE greater than 3)\n\nPsychiatric conditions or behavior that would be incompatible with safe and successful participation in this study\n\nCurrent use of medications/dietary supplements/alternative therapies known to alter thyroid function, energy expenditure or bile acid secretion\n\nHistory of weight loss or weight gain of greater than 3 percent body weight over the past 2 months (self-reported)\n\nPregnancy/breastfeeding/hormonal contraceptive use and childbirth within the last 6 months\n\nPerimenopausal (as self-described within two years from onset of amenorrhea or current complaints of hot flashes)\n\nCurrent smoker","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Energy Expenditure","description":"Energy expenditure is measured over 6 hours in a respiratory chamber for each intervention and placebo.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.37","spread":"0.11"},{"groupId":"OG001","value":"1.40","spread":"0.09"},{"groupId":"OG002","value":"1.28","spread":"0.06"},{"groupId":"OG003","value":"1.27","spread":"0.05"},{"groupId":"OG004","value":"1.28","spread":"0.05"}]}]}]},{"type":"PRIMARY","title":"Bile Acid","description":"Bile acid is measured at 0, 60, 90 and 360 minutes during a 6 hour stay in in a respiratory chamber for each intervention and placebo. The mean of these 4 values is then calculated.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.89","spread":"0.85"},{"groupId":"OG001","value":"7.26","spread":"4.6"},{"groupId":"OG002","value":"2.42","spread":"0.64"},{"groupId":"OG003","value":"5.17","spread":"1.20"},{"groupId":"OG004","value":"2.69","spread":"0.73"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":31},"commonTop":[]}}}